Dr. Suzanne Slonim Achieves 97% Success Rate for Female Uterine Fibroid Cases

Fibroid expert Dr. Suzanne Slonim, of Precision VIR in Dallas, TX, achieves 97% clinical success rate in nonsurgical treatments of female uterine fibroid cases. She works to raise awareness of fibroid symptoms, risk factors, and the UFE treatment for women as an alternative to hysterectomy.

Dallas, United States - June 14, 2018 /PressCable/ —

Slonim Raises Awareness of Fibroid Symptoms, Risk Factors, and Treatment Options for Women

Dallas, TX (June 14, 2018) – Dr. Suzanne Slonim, a uterine fibroid expert in Dallas, Texas, with her team at Precision Vascular & Interventional (Precision VIR), has reached a staggering 97 percent clinical success rate in treating female uterine fibroid cases. The procedure, known as uterine fibroid embolization (UFE), causes fibroid tumors to shrink and is a less-invasive option than a hysterectomy or myomectomy.

“It’s critical for women to be informed that they have choices,” said Dr. Slonim. “Helping women is why I became a doctor. It’s what I love to do. It’s my honor to help women avoid a hysterectomy and improve their lives.” Dr. Slonim added, “And when they express their gratitude, it means the world to me.”

A board-certified vascular and interventional radiologist of 23 years, Dr. Slonim is recognized as a leading expert in UFE while helping many women with uterine fibroids avoid hysterectomy surgery. She is the driving force behind the #FibroidFree movement in the Dallas-Fort Worth area and is on a mission to educate, inform, and treat women who are interested in UFE and want to take charge of their health.

Dr. Slonim’s clinical success rate is evident in the many five-star reviews and supportive comments from patients she has received over the years. For example, one patient of hers had been bleeding every single day for eight months. Since Dr. Slonim performed the UFE procedure, she only bleeds during her periods, and her flow is very light. Another woman was having terrible back pain every day. Since UFE, she has zero back pain. A third patient was staying home from work each month during her period because of debilitating cramps. Since the UFE, she hasn’t missed a day of work. The success stories from Dr. Slonim’s patients go on and on, and several are featured on the practice YouTube Channel and on Facebook.

“I’ve always been interested in women’s health,” Dr. Slonim explains. “I want to help women avoid surgery if they can. I want them to know all their treatment options for fibroids. I know UFE is effective, and I enjoy doing it. When I left my old practice, I had the opportunity to focus my attention where I wanted to. I jumped at the chance to build a practice dedicated to UFE.”

About Women’s Fibroids and UFE

By age 60, one in every three women has had a hysterectomy; the most common reason is fibroids. Uterine fibroids are noncancerous tumors located in and around the uterus. Though usually benign, fibroids can cause life-altering symptoms such as heavy menstrual bleeding, anemia, blood clots, irregular blood levels, frequent urination, and severe pelvic pain.

Fibroids don’t always cause problems, and they are often discovered during tests for other conditions. Uterine fibroids most often affect women between the ages of 30 and 50. Also noteworthy is that African-American women are three times more likely to develop uterine fibroids, followed by Hispanics, Whites and Asians.

Most women suffer in silence because they hear the word “fibroids” and think surgery. This is no longer the case with UFE, which is less invasive, safer, and has a faster recovery time than surgical procedures. For those who are eligible, UFE can be performed through the wrist artery.

Advantages of UFE include:

• Recovery time of 5-7 days

• No hospital stay; no surgery

• Procedure time at or under 1 hour

Despite being pioneered in the mid-1990s and covered by most insurance companies, uterine fibroid embolization (UFE) treatment is surprisingly unknown. After UFE, in addition to living pain-free, several patients have become pregnant and are new mothers. In turn, Dr. Slonim is known for keeping in contact with patients who now enjoy life fibroid free.

“I learn from every patient I meet and from every procedure I perform,” Dr. Slonim said. “The more patients’ stories I hear, the more unusual symptoms I can store away in my memory as possibly related to fibroids. The more women I examine, the more likely I am to notice something out of the ordinary. The more times I treat extremely large fibroids, the surer I can be that the UFE will be successful. Experience increases skill level in almost every field.”

Dr. Slonim added, “The fact that my current team at the Precision VIR office has completed hundreds of cases together helps us work better together. We know our strengths. We can anticipate each other’s needs. We work together incredibly smoothly. All of that means we can take care of each patient better.”

About Fibroid Free & Precision VIR

Fibroid Free is a division of Precision Vascular and Interventional Radiology. Precision VIR is the first independent vascular and interventional radiology practice in North Texas. Established in 2012, Precision VIR evaluates, diagnoses and treats vascular conditions such as varicose veins, chronic venous insufficiency, peripheral arterial disease, pelvic congestion syndrome, and varicocele. The specialists at Precision VIR also focus on treating fibroids without surgery using Uterine Fibroid Embolization (UFE).

Dr. Slonim was a welcome addition to the Precision VIR team in 2016. She is thrilled to be a part of a unique practice that enables patients to benefit from interventional radiology treatments in the comfort of a medical office rather than a hospital.

To schedule a free phone consultation with Dr. Suzanne Slonim, call 214-377-0220, visit FibroidFree.com or PrecisionVIR.com.

– end –

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com

Source: PressCable

Release ID: 359911

More News From Science Of The World

ProSieben, Discovery to build German TV streaming platform

Jun 25, 2018

By Jörn Poltz and Douglas BusvineMUNICH/FRANKFURT (Reuters) - ProSiebenSat.1 Media and Discovery Inc plan to join forces to build a German TV streaming platform to challenge U.S. giants Netflix , Amazon Prime and YouTube.The 50-50 partnership would be based on the existing 7TV alliance formed last year, and bring in ProSieben's Maxdome video-on-demand offering and Discovery's Eurosport Player, the partners said on Monday.It marks the first strategic move by ProSieben's new CEO Max Conze, who took charge on June 1 after his predecessor was undone by weak advertising revenues at the Munich broadcaster's core free-to-air channels."It is our clear vision...

Clamor for GSK shingles shot points to bigger profits

Jun 25, 2018

By Ben HirschlerLONDON (Reuters) - GlaxoSmithKline is facing "unprecedented" demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analysts initially thought.In the short term, though, GSK faces a problem. While more than 1.5 million Americans have received Shingrix since the end of last year, others are having to wait, prompting the U.S. Centers for Disease Control and Prevention (CDC) to warn of shortages.GSK said it had increased deliveries significantly and was vaccinating people against shingles far faster than in the past, when Merck & Co's Zostavax was the only product...

EU in agreement with Amazon, eBay to tackle dangerous product listings

Jun 25, 2018

BRUSSELS (Reuters) - The European Commission has signed an agreement with four major online retailers to combat the listing of dangerous products on Europe's online shopping sites.Dangerous content, as defined by the Commission, includes anything from incitement to hatred and violence to child sexual abuse material, unsafe products and products infringing copyright.AliExpress, Amazon, eBay and Rakuten-France agreed to remove dangerous product listings within two days of being notified by authorities and respond to customer notifications within five days.The Commission said 20 percent of sales in Europe were made online in 2016, increasing the prevalence of dangerous product listings."E-commerce has opened...

Stocks fall on report US may limit tech exports to China

Jun 25, 2018

NEW YORK — U.S. stocks are falling Monday morning following losses in Europe and Asia, and technology companies are skidding after The Wall Street Journal reported that the Trump administration plans to limit high-tech exports to China and will limit Chinese investment in American technology companies. Harley-Davidson is falling after it said it will shift the production of some motorcycles to Europe in response to taxes the EU put on U.S. exports. KEEPING SCORE: The S&P 500 index shed 27 points, or 1 percent, to 2,727 as of 10 a.m. Eastern time. The Dow Jones Industrial Average lost 275 points,...

We've changed, Uber says, in court battle to keep London license

Jun 25, 2018

By Alistair SmoutLONDON (Reuters) - Uber [UBER.UL] accepted it had made mistakes but said it had changed as it went to court on Monday to overturn a decision stripping it of its license in London after it was ruled unfit to run a taxi service in its most important European market. Regulator Transport for London (TfL) shocked the Silicon Valley firm last September by refusing to renew its license, citing failings in its approach to reporting serious criminal offences and to background checks on drivers.Uber, backed by Goldman Sachs and BlackRock among others and valued at over $70 billion, has...

About Us

Started in 2015, Science Of The World offers in-depth news about the latest scientific discoveries. If you’re looking for a reliable source, Science Of The World is the one for you.

Contact us: sales[at]scienceoftheworld.com

Subscribe Now!